Moxifloxacin Causing Lazy Heart: A Case Report

Case Report | DOI: https://doi.org/10.31579/2690-8808/257

Moxifloxacin Causing Lazy Heart: A Case Report

  • Ashfaq A 1*
  • Ashfaq R 2

1 Diploma, Health Office Administration, Canada.

2 Pakistan Atomic Energy Commission General Hospital, Islamabad, Pakistan.

*Corresponding Author: Anum Ashfaq, Specialist in General Medicine, Pakistan Atomic Energy Commission General Hospital, Islamabad, Pakistan.

Citation: Ashfaq A, Ashfaq R, (2025), Moxifloxacin Causing Lazy Heart: A Case Report, J, Clinical Case Reports and Studies, 6(4); DOI:10.31579/2690-8808/257

Copyright: ©, 2025, Anum Ashfaq. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 23 May 2025 | Accepted: 30 May 2025 | Published: 06 June 2025

Keywords: bradycardia; moxifloxacin; electrocardiography; qt interval

Abstract

Bradycardia is defined as heart rate less than 60bpm in adults (Normal heart rate is 60-100bpm in adults). There are many causes of bradycardia including medications which can cause mild to severe depression in heart rate even leading to cardiac arrest and death. Here is the case of an elderly man with no pre-morbid condition who took moxifloxacin for the treatment of acute rhinosinusitis. He developed dizziness and generalized fatigue on second day of antibiotic treatment. His complete blood picture, liver function tests, renal function tests, serum electrolytes including magnesium and potassium were all normal. ECG showed sinus bradycardia. Echocardiography was normal. His moxifloxacin was switched to amoxicillin-clavulanate and his bradycardia reverted back to normal.

Introduction

In adult individuals, normal heart rate varies between 60 and 100 bpm. Athletes have slightly lower heart rates as compared to non-athletes. Bradycardia is defined as heart rate less than 60bpm in adults. There are many causes of bradycardia which includes hypokalemia, hypomagnesemia, female sex, older age group, pre-existing heart diseases and medications which can cause mild to severe bradycardia and torsades de pointes (TdP) eventually can resulting in ventricular fibrillation, cardiac arrest and death. Symptoms of bradycardia include dizziness, fatigue, lightheadedness, breathlessness and chest pain. In most of the cases previously documented, most patients had torsades de pointes as a complication of moxifloxacin but in our case, patient developed sinus bradycardia. But to keep it in strong consideration, bradycardia can ultimately leads to torsades de pointes, ventricular fibrillation and cardiac arrest.

Case Presentation:

A 69-years old elderly patient with no known pre-morbids presented in hospital OPD with symptoms of acute rhinosinusitis. His ENT specialist advised him moxifloxacin for 7 days. On second day of treatment, he developed dizziness and generalized fatigue. He visited emergency department for symptoms. His blood pressure was 100/60mmHg, pulse was 48bpm, oxygen saturation 98% and was afebrile. 

Electrocardiography was done which showed sinus bradycardia with no missed beats or any arrhythmia. His baseline investigations like complete blood picture, liver function tests, renal function tests, serum electrolytes including potassium and magnesium, and thyroid function tests all were normal. Echocardiography was done to rule out any underlying cardiac disease which also came out to be normal.

He was not taking any other medications. So, his moxifloxacin was withheld and switched to amoxicillin-clavulanate for the treatment of acute rhinosinusitis. His bradycardia improved after one day and returned back to 68bpm with improvement of symptoms.

Discussion:

Antibiotics are necessary for Acute bacterial Rhinosinusitis. There are different groups of antibiotic groups indicated for acute rhinosinusitis. Common groups include respiratory fluoroquinolones, amoxicillin-clavulanate or a third-generation cephalosporin plus clindamycin. In group of fluoroquinolones, researches have showed that Moxifloxacin is superior to Levofloxacin in terms of shorter duration of treatment and better outcomes along with low recurrence rates. [1]

Moxifloxacin can cause lethal outcomes as it is a stronger antibiotic with longer half-life but can cause prolonged QTc interval, bradycardia, and torsades de pointes (TdP) which is a life threatening condition and leads to ventricular arrhythmias and death. [2] Bradycardia can cause decreased cardiac output and in turn causing hypotension and hypoperfusion which can lead to Myocardial Infarction and sudden Cardiac Arrest especially in people of an older age group and with people of already diagnosed cardiac problems. [3]

Clinicians should avoid prescribing Moxifloxacin in previously diagnosed cardiac patients and in elderly people. Younger patients must be informed in detail about symptoms of bradycardia such as dizziness, fatigue, dyspnea, or chest pain with emergency follow up if these occur; as some people are genetically susceptible to QTc prolongation. [4] They should also take proper family history of sudden cardiac arrest in younger people before prescribing moxifloxacin. An electrocardiogram can be done in hospital or in OPD setting to look for silent QTc prolongation before prescribing moxifloxacin. It is better to give moxifloxacin in hospital setting where there is proper monitoring of cardiac status is available and emergency management can be done.

There are Effective alternatives of moxifloxacin. Treating physicians should see the pros and cons of prescribing fluoroquinolones in the treatment of acute bacterial rhinosinusitis. They should choose as effective antibiotic as moxifloxacin with less side effects. Clinicians can prescribe Amoxicillin/Clavulanate as an effective and equivalent alternative to Moxifloxacin with better safety profile. [5]

Conclusion:

Many medications cause rare complications. We should keep in mind these rare complications as a cause of patient’s newly developed symptoms and to avoid any further life-threatening events.

Conflict of Interest

No conflict of interest with any institution / organization.

Funding: 

No grant or fellowship supporting the writing of the paper.

Author’s contribution:

both authors fulfilling the ICMJE criteria.

References

Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.

img

Dr Elena Popa

It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.

img

Dr Nikolaos Andreas Chrysanthakopoulos

Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee

img

Robert W McGee

Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D

img

Aibing Rao

I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.

img

Kashani Mehdi

Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,

img

Alla Konstantinovna Politova